ITMI20042042A1 - Derivati solfonammidici antagonisti del recettore dei vanilloidi trpv1 - Google Patents

Derivati solfonammidici antagonisti del recettore dei vanilloidi trpv1

Info

Publication number
ITMI20042042A1
ITMI20042042A1 IT002042A ITMI20042042A ITMI20042042A1 IT MI20042042 A1 ITMI20042042 A1 IT MI20042042A1 IT 002042 A IT002042 A IT 002042A IT MI20042042 A ITMI20042042 A IT MI20042042A IT MI20042042 A1 ITMI20042042 A1 IT MI20042042A1
Authority
IT
Italy
Prior art keywords
derivatives
solfonamid
antagonist
vanilloid receptor
receptor trpv1
Prior art date
Application number
IT002042A
Other languages
English (en)
Italian (it)
Original Assignee
Pharmeste Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmeste Srl filed Critical Pharmeste Srl
Priority to IT002042A priority Critical patent/ITMI20042042A1/it
Publication of ITMI20042042A1 publication Critical patent/ITMI20042042A1/it
Priority to EP05796943A priority patent/EP1805138B1/en
Priority to DE602005005512T priority patent/DE602005005512T2/de
Priority to US11/577,857 priority patent/US7579378B2/en
Priority to AT05796943T priority patent/ATE389634T1/de
Priority to PCT/EP2005/011206 priority patent/WO2006045498A1/en
Priority to ES05796943T priority patent/ES2303275T3/es
Priority to JP2007537190A priority patent/JP5080260B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/18—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
    • C07C335/10—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C335/12—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IT002042A 2004-10-26 2004-10-26 Derivati solfonammidici antagonisti del recettore dei vanilloidi trpv1 ITMI20042042A1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT002042A ITMI20042042A1 (it) 2004-10-26 2004-10-26 Derivati solfonammidici antagonisti del recettore dei vanilloidi trpv1
EP05796943A EP1805138B1 (en) 2004-10-26 2005-10-18 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor
DE602005005512T DE602005005512T2 (de) 2004-10-26 2005-10-18 Antagonisten des Vanilloid-Rezeptors, insbesondere Sulfonamidderivate, welche den TRPV1-Rezeptor antagonisieren
US11/577,857 US7579378B2 (en) 2004-10-26 2005-10-18 Sulfonamido compounds that antagonize the vanilloid TRPV1 receptor
AT05796943T ATE389634T1 (de) 2004-10-26 2005-10-18 Den vanilliod-trpv1-rezeptor antagonisierende sulfonamidoverbindungen
PCT/EP2005/011206 WO2006045498A1 (en) 2004-10-26 2005-10-18 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor
ES05796943T ES2303275T3 (es) 2004-10-26 2005-10-18 Compuestos sulfonamido que antagonizan con el receptor vaniloide trpv1.
JP2007537190A JP5080260B2 (ja) 2004-10-26 2005-10-18 バニロイドｔｒｐｖ１受容体に拮抗するスルホンアミド化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002042A ITMI20042042A1 (it) 2004-10-26 2004-10-26 Derivati solfonammidici antagonisti del recettore dei vanilloidi trpv1

Publications (1)

Publication Number Publication Date
ITMI20042042A1 true ITMI20042042A1 (it) 2005-01-26

Family

ID=35501228

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002042A ITMI20042042A1 (it) 2004-10-26 2004-10-26 Derivati solfonammidici antagonisti del recettore dei vanilloidi trpv1

Country Status (8)

Country Link
US (1) US7579378B2 (enExample)
EP (1) EP1805138B1 (enExample)
JP (1) JP5080260B2 (enExample)
AT (1) ATE389634T1 (enExample)
DE (1) DE602005005512T2 (enExample)
ES (1) ES2303275T3 (enExample)
IT (1) ITMI20042042A1 (enExample)
WO (1) WO2006045498A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1861357B1 (en) * 2005-03-19 2013-04-24 Amorepacific Corporation Novel compounds or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
WO2009081222A1 (en) 2007-12-21 2009-07-02 Glenmark Pharmaceuticals, S.A. Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands
CN106146362B (zh) * 2015-04-15 2018-04-03 南京理工大学 一种合成c‑7280948的方法
CN107759477A (zh) * 2017-11-20 2018-03-06 阿里化学(常州)有限公司 一种对硝基苯乙胺盐酸盐的生产制备方法
EP4074317A1 (en) 2021-04-14 2022-10-19 Bayer AG Phosphorus derivatives as novel sos1 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0693386B1 (en) 1994-07-21 1997-02-05 Nippon Paper Industries Co., Ltd. Aminobenzenesulfonamide derivatives as colour-developers for thermosensitive recording materials
ATE328868T1 (de) * 2000-08-21 2006-06-15 Pacific Corp Neue (thio)harnstoffverbindungen und arzneimittelkompositionen, die diese enthalten
DE60133743T2 (de) * 2000-08-21 2009-07-02 Pacific Corp. Neue thiourea-derivate und pharmazeutische zusammensetzungen die diese enthalten
WO2002070467A1 (en) * 2001-02-26 2002-09-12 4Sc Ag Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments

Also Published As

Publication number Publication date
US20090118374A1 (en) 2009-05-07
EP1805138B1 (en) 2008-03-19
WO2006045498A1 (en) 2006-05-04
DE602005005512D1 (de) 2008-04-30
DE602005005512T2 (de) 2009-04-16
JP2008517884A (ja) 2008-05-29
EP1805138A1 (en) 2007-07-11
US7579378B2 (en) 2009-08-25
JP5080260B2 (ja) 2012-11-21
ATE389634T1 (de) 2008-04-15
ES2303275T3 (es) 2008-08-01

Similar Documents

Publication Publication Date Title
ATE544767T1 (de) Triazoloä4,5-düpyramidinderivate und deren verwendung als purinrezeptorantagonisten
UY30444A1 (es) Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.
CL2010001348A1 (es) Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad.
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
ATE483707T1 (de) 2-cyclopropylthiazolderivate
CR20120634A (es) Derivados de heteroaril imidazolona como inhibidores de jak
UY31124A1 (es) Derivados de oxiadazol y su uso como potenciadores del receptor metabotropico de glutamato - 842
EA201071291A2 (ru) Nmda рецепторные антагонисты для лечения нейропсихиатрических расстройств
UY30748A1 (es) Compuesto0s novedosos
HRP20070076A2 (en) Pyrimidine derivatives
NO20071074L (no) Substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
GT201200207A (es) Derivados de imidazopiridina como inhibidores de jak
EA201100007A1 (ru) Производные хиноксалиндиона
EA200801996A1 (ru) 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов
MX2010003224A (es) Derivados de biaril sulfonamida.
EA201600636A1 (ru) 2-амино-6-метил-4,4а,5,6-тетрагидропирано[3,4-d][1,3]тиазин-8а(8н)-ил-1,3-тиазол-4-ил амиды
EA201190320A1 (ru) Гетероциклические сульфонамиды, их применения и фармацевтические композиции
CR10497A (es) Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38
SMT201200017B (it) Nuovi antagonisti P2X7R e il loro uso.
EA200700601A1 (ru) Производные фениламинопиримидина как ингибиторы bcr-abl
ATE521609T1 (de) Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs
GT200600081A (es) Derivados de acetilenno
CR10371A (es) Compuestos heterociclicos apropiados para tratar trastornos que responden a la moduilacion del receptor de serotonina 5ht6
ATE445593T1 (de) Acetylenderivate
UY30424A1 (es) Derivados de quinolina, su preparacion, su uso y medicamentos que comprenden los mismos.